This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.
Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical…
July 9, 2018
Discontinuation of nucleos(t)ide analogue therapy for chronic hepatitis B correlated with risk for clinical relapse…